Showing 1 - 10 of 13
Developing countries have recently proved reluctant to participate in sovereign debt moratoria and debt relief initiatives. We argue that debtors' (non-)participation decisions can be understood through the lens of real options. Eligible countries compare the net benefits of participating in a...
Persistent link: https://www.econbiz.de/10014343135
Persistent link: https://www.econbiz.de/10014335108
Developing countries have recently proved reluctant to participate in sovereign debt moratoria and debt relief initiatives. We argue that debtors' (non-)participation decisions can be understood through the lens of real options. Eligible countries compare the net benefits of participating in a...
Persistent link: https://www.econbiz.de/10015059254
Persistent link: https://www.econbiz.de/10001142720
We study the determinants of new and repeated research collaborations, drawing on the co-authorship network of the International Monetary Fund (IMF)'s Working Papers series. Being an outlet where authors express their views on topics of interest, and given that IMF staff is not subject to the...
Persistent link: https://www.econbiz.de/10014408846
We study the determinants of new and repeated research collaborations, drawing on the co-authorship network of the International Monetary Fund (IMF)'s Working Papers series. Being an outlet where authors express their views on topics of interest, and given that IMF staff is not subject to the...
Persistent link: https://www.econbiz.de/10013249731
Persistent link: https://www.econbiz.de/10001215045
The valuation of multi-staged pharmaceutical R&D can be interpreted as a chain of real options. In valuing these compound option models, a crucial problem is how to deal with the different types of risk. Previous models, such as Cassimon et al. (2004), offer a closed-form solution for the...
Persistent link: https://www.econbiz.de/10014162803
Persistent link: https://www.econbiz.de/10009379464
Persistent link: https://www.econbiz.de/10011537964